A Cross-sectional Study of the Relationship Between Habitual Tea Consumption and Arterial Stiffness

Lin, Qing-Fei; Qiu, Changsheng; Wang, Sai-lan; Huang, Lifang; Chen, Zhi-yuan; Chen, Yun; Chen, Gang

doi:10.1080/07315724.2015.1058197

Cited by 23 publications

(11 citation statements)

References 35 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The tested daily doses ranged from 250 to 1200 mg of green tea extract or from 170 to 850 mg of EGCG [143]. Moreover, green tea is associated with an improvement in FMD [144] and pulse wave velocity (PWV) [145], despite no apparent effect on hs-CRP levels [146]. Therefore, overall the consumption of green tea might be associated with a decreased risk of CVD morbidity and mortality [147].…”

Section: Green Tea Extractsmentioning

confidence: 99%

Lipid-lowering nutraceuticals in clinical practice: position paper from an International Lipid Expert Panel

et al. 2017

View full text Add to dashboard Cite

In recent years, there has been growing interest in the possible use of nutraceuticals to improve and optimize dyslipidemia control and therapy. Based on the data from available studies, nutraceuticals might help patients obtain theraputic lipid goals and reduce cardiovascular residual risk. Some nutraceuticals have essential lipid-lowering properties confirmed in studies; some might also have possible positive effects on nonlipid cardiovascular risk factors and have been shown to improve early markers of vascular health such as endothelial function and pulse wave velocity. However, the clinical evidence supporting the use of a single lipid-lowering nutraceutical or a combination of them is largely variable and, for many of the nutraceuticals, the evidence is very limited and, therefore, often debatable. The purpose of this position paper is to provide consensus-based recommendations for the optimal use of lipid-lowering nutraceuticals to manage dyslipidemia in patients who are still not on statin therapy, patients who are on statin or combination therapy but have not achieved lipid goals, and patients with statin intolerance. This statement is intended for physicians and other healthcare professionals engaged in the diagnosis and management of patients with lipid disorders, especially in the primary care setting.

show abstract

Section: Green Tea Extractsmentioning

confidence: 99%

Lipid-lowering nutraceuticals in clinical practice: position paper from an International Lipid Expert Panel

et al. 2017

View full text Add to dashboard Cite

show abstract

“…Therefore, improvement in arterial elasticity is another mechanism for prevention of hypertension. To explore the relationship between habitual tea consumption and arterial stiffness, Lin et al [37] performed a cross-sectional, epidemiological survey of 6,589 male and female residents aged 40–75 years, in Wuyishan, Fujian Province, China. The results showed that the levels of brachial-ankle pulse wave velocity (ba-PWV) were lowest amongst subjects who consumed tea habitually for more than 10 years, compared with the other 3 subgroups (nonhabitual, 1–5 year, and 6–10 year habitual tea drinkers).…”

Section: Tea Regulating Blood Pressure In Human Intervention Studiesmentioning

confidence: 99%

Effects and Mechanisms of Tea Regulating Blood Pressure: Evidences and Promises

Wang

Huang

et al. 2019

Nutrients

View full text Add to dashboard Cite

Cardiovascular diseases have overtaken cancers as the number one cause of death. Hypertension is the most dangerous factor linked to deaths caused by cardiovascular diseases. Many researchers have reported that tea has anti-hypertensive effects in animals and humans. The aim of this review is to update the information on the anti-hypertensive effects of tea in human interventions and animal studies, and to summarize the underlying mechanisms, based on ex-vivo tissue and cell culture data. During recent years, an increasing number of human population studies have confirmed the beneficial effects of tea on hypertension. However, the optimal dose has not yet been established owing to differences in the extent of hypertension, and complicated social and genetic backgrounds of populations. Therefore, further large-scale investigations with longer terms of observation and tighter controls are needed to define optimal doses in subjects with varying degrees of hypertensive risk factors, and to determine differences in beneficial effects amongst diverse populations. Moreover, data from laboratory studies have shown that tea and its secondary metabolites have important roles in relaxing smooth muscle contraction, enhancing endothelial nitric oxide synthase activity, reducing vascular inflammation, inhibiting rennin activity, and anti-vascular oxidative stress. However, the exact molecular mechanisms of these activities remain to be elucidated.

show abstract

“…Further potentiation of these chemo‐protective properties can occur when the gut interacts with a colonic microbiome and metabolic conversion to smaller more potent phenolic substances than their parent compounds occur 24 . The molecular attributes of these cellular proteins and signalling pathways influence other downstream pleiotropic effects such as decreased arterial stiffness, 25 reductions in LDL cholesterol, 26 lower insulin resistance, improved glycemic control, and a lower risk of metabolic syndrome and diabetes mellitus 19 . Although transient increases in blood pressure following short‐term administration of coffee has been noted, 27 it has not translated to a long‐term risk for hypertension 28 .…”

Section: Discussionmentioning

confidence: 99%

Coffee and tea consumption in the early adult lifespan and left ventricular function in middle age: the CARDIA study

et al. 2020

View full text Add to dashboard Cite

Aims The long-term impact of coffee or tea consumption on subclinical left ventricular (LV) systolic or diastolic function has not been previously studied. We examined the association between coffee or tea consumption beginning in early adulthood and cardiac function in midlife. Methods and results We investigated 2735 Coronary Artery Risk Development in Young Adults (CARDIA) study participants with long-term total caffeine intake, coffee, and tea consumption data from three visits over a 20 year interval and available echocardiography indices at the CARDIA Year-25 exam (2010-2011). Linear regression models were used to assess the association between caffeine intake, tea, and coffee consumption (independent variables) and echocardiography outcomes [LV mass, left atrial volume, and global longitudinal strain (GLS), LV ejection fraction (LVEF), and transmitral Doppler early filling velocity to tissue Doppler early diastolic mitral annular velocity (E/e´)]. Models were adjusted for standard cardiovascular risk factors, socioeconomic status, physical activity, alcohol use, and dietary factors (calorie intake, whole and refined grain intake, and fruit and vegetable consumption). Mean (standard deviation) age was 25.2 (3.5) years at the CARDIA Year-0 exam (1985-1986), 57.4% were women, and 41.9% were African-American. In adjusted multivariable linear regression models assessing the relationship between coffee consumption and GLS, beta coefficients when comparing coffee drinkers of <1, 1-2, 3-4, and >4 cups/day with non-coffee drinkers were β = À0.30%, P < 0.05; β = À0.35%, P < 0.05; β = À0.32%, P < 0.05; β = À0.40%, P > 0.05; respectively (more negative values implies better systolic function). In adjusted multivariable linear regression models assessing the relationship between coffee consumption and E/e´, beta coefficients when comparing coffee drinkers of <1, 1-2, 3-4, and >4 cups/day with non-coffee drinkers were β = À0.29, P < 0.05; β = À0.38, P < 0.01; β = À0.20, P > .05; and β = À0.37, P > 0.05, respectively (more negative values implies better diastolic function). High daily coffee consumption (>4 cups/day) was associated with worse LVEF (β = À1.69, P < 0.05). There were no associations between either tea drinking or total caffeine intake and cardiac function (P > 0.05 for all). Conclusions Low-to-moderate daily coffee consumption from early adulthood to middle age was associated with better LV systolic and diastolic function in midlife. High daily coffee consumption (>4cups/day) was associated with worse LV function. There was no association between caffeine or tea intake and cardiac function.

show abstract

A Cross-sectional Study of the Relationship Between Habitual Tea Consumption and Arterial Stiffness

Abstract: Habitual tea consumption may have a protective effect against arterial stiffness, especially for subjects who have habitually consumed tea for more than 6 years and >10 g daily.

Cited by 23 publications

References 35 publications

Lipid-lowering nutraceuticals in clinical practice: position paper from an International Lipid Expert Panel

Lipid-lowering nutraceuticals in clinical practice: position paper from an International Lipid Expert Panel

Effects and Mechanisms of Tea Regulating Blood Pressure: Evidences and Promises

Coffee and tea consumption in the early adult lifespan and left ventricular function in middle age: the CARDIA study

Contact Info

Product

Resources

About